To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

October 04, 2018

Today's Rundown

Featured Story

Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug

Johnson & Johnson has paid $175 million upfront for the global rights to Arrowhead’s phase 1/2 RNAi hepatitis B drug. The outlay, plus $1.6 billion in milestones, has bought J&J a drug that slashed levels of hepatitis B virus in a small, early-phase assessment.

Top Stories

Private equity giant Blackstone buys Clarus in biopharma push

Blackstone has struck a deal to buy Clarus. The takeover will move private equity giant Blackstone deeper into biopharma, where it plans to use its financial might to fund R&D programs that have outgrown the means of traditional venture capital firms. 

DDF 2018: Diversity can fuel company growth outside of a strong profit case

To best address diversity, or a lack thereof, companies need to build formal, proactive systems within their organizations—not only to gather a wide array of perspectives but also to help new employees feel invested in the company more quickly and to help them do their best work.

This year’s Fierce 15 winners on burgeoning biotech investment and the decade ahead

This year’s class of Fierce 15 landed during a banner year for venture capital investment in biotech. We asked them if they thought the trend would continue or if the bubble would burst.

Sarepta sees muscle function gains with DMD gene therapy

Preliminary signs of improved muscle function have been seen in Sarepta's Duchenne muscular dystrophy gene therapy trial.

DDF 2018: Approaching accelerated approvals in multiple markets

Other regions are catching up to the U.S. in terms of accelerated approval pathways, but companies will need to take a more holistic approach to succeed on the global scale.

BIO’s ultimatum to members: Get serious about gender diversity or face our fury

After an unofficial party at this year’s BIO convention stirred up controversy, the biotech industry’s largest trade association is tightening the screws on its members to step up gender diversity—and show a little respect at their parties—or else.

Enrollment Showcase

Online Graduate Programs Designed for Your Career

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.

Resources

[Research] Linguistic and Cultural Considerations When Implementing a Global BYOD Study

Examine the linguistic and cultural considerations of global eCOA and BYOD.

[eBook] Healthcare and Life Sciences - Data Value Chain

Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data.

[Infographic] Flexible. Scalable. Proactive.

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[Case Study] FSP Insourcing – Relationship Growth Built on Results, Trust

Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries.

[POCKET GUIDE] 3 Steps To Supercharge Your Literature Search

Go from Search to Full-Text Scientific Papers in a Single Click!

[eBook] Digital Workflows: How to Focus Investment to Cut Costs and Drive Growth

Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin?

[Whitepaper] How to Re-Design your Regulatory Capabilities

A top 20 pharma and growing biotech re-engineer regulatory processes.

[Whitepaper] The Future of Pharmacovigilance: Leveraging Technology and Automation

Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be!

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

[Webinar] Enabling precision medicine with Tableau and AWS

Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children.

[Webinar] Build a holistic data management strategy for Life Sciences

Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS.

[Webinar] Safeguard your Life Sciences data with Druva and AWS

Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data.

[eLearning] BIOAVAILABILITY 101

Develop a basic understanding of principles and concepts of bioavailability of oral drugs.

Events

.